Speaker
Michele Colucci
(Istituto Nazionale di Fisica Nucleare)
Summary
Terbium radionuclides are emerging as key isotopes for theranostic applications, offering matched pairs for imaging and therapy. Among them, 155Tb is a promising SPECT radionuclide suitable for dosimetric validation of therapeutic analogues such as 161Tb and ¹⁷⁷Lu. Its routine production, however, remains challenging due to limited yields from direct reactions and the scarcity of enriched target material. The APHRODITE-155 project explores an indirect production route based on the decay of 155Dy obtained through 159Tb(p,x) nuclear reactions, integrating nuclear data acquisition, process modeling, and radiochemical separation optimization.
| Are you interested/eligible for the Young Session? | Yes, I am eligible and interested in participating |
|---|
Author
Michele Colucci
(Istituto Nazionale di Fisica Nucleare)
Co-authors
Arnaud GUERTIN
(CNRS/IN2P3/SUBATECH)
Etienne NIGRON
(GIP ARRONAX)
Ferid Haddad
Flavia Maria Groppi
(Istituto Nazionale di Fisica Nucleare)
Nadia Audouin
(GIP Arronax)
Simone Manenti
(Department of Physics, University of Milan)
Thomas Sounalet
(Subatech)
